Data_Sheet_2_Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer A... by Gurbet Tutumlu (8691720)

“…In the first approach, a molecular docking and filtering approach is used to rank compounds based on their docking scores and only a few top-ranked molecules are selected for further long (100-ns) molecular dynamics (MD) simulations and in vitro tests. …”

The Effect of Symmetric and Asymmetric NHCs on the Structure and Catalytic Properties of Dialkylgallium Alkoxides in the Ring-Opening Polymerization of <i>rac</i>-LactideLinking t... by Anna Maria Dąbrowska (1859476)

“…The much smaller cavity of <b>4</b> led to a minor activity and lower isoselectivity (<i>P</i>_m‑max = 0.56 at −20 °C). …”

Expression of mesoderm and primitive streak markers in <i>Cul4b</i>-null embryos. by Chun-Yu Chen (486495)

“…(C, D) A slight decrease in Brachyury was detected at E7.5 in <i>Cul4b</i>^<i>Δ/</i><i>Y</i> embryos. …”

Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Gastrointestinal symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Subgroup analysis of angina pectoris attack time. by Xiaoqi Wu (9503481)

“…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”

Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Retinoic acid signaling responsiveness in the periocular region. by Glenda Evangelina Comai (9652709)

“…BMS493 treatment before and after tamoxifen induction reveals a drastic decrease in GFP+ cells in the periocular region (<b>I</b>) compared with controls (<b>G</b>). …”

Safety and EEG data quality of concurrent high-density EEG and high-speed fMRI at 3 Tesla by Mette Thrane Foged (4050703)

“…The degree of artifacts and the ability to identify background activity was assessed by visual analysis by a trained expert in the 64 channel EEG data (7 healthy controls, 13 patients).…”

Meta-analysis off requency of angina attacks. by Xiaoqi Wu (9503481)

“…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”

Flow of patients in Halos trial. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Meta-analysis of angina pectoris attack time. by Xiaoqi Wu (9503481)

“…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”

Cough-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Supplementary Figures from Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells by Xueheng Zhao (7024310)

“…*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 (two-tailed t test) Supplementary Figure 5 Ganglioside GM3 (d34:1), GM3 (d34:0) and GM3 (d34:2) decrease in NTsh, FANCD2sh and FANCJsh UMSCC-1 cells after NB-DNJ exposure Supplementary Figure 6 NTsh and FANCD2sh NIKS cells (a) and UMSCC-47 cells (b) were plated at equal cell numbers, and NB-DNJ was added following cell attachment, and replenished in fresh media after 24 hrs</p>…”

Dyspnea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

S1 Graphical abstract - by Huimin Xian (20390006)

“…Quantitative flow ratio (QFR), as a newer non-invasive tool for identifying functional coronary stenosis and determining the presence of functional CR (FCR), may open up a new perspective for studying the above issues. …”

Altered gene expression in diapausing flies assessed by qPCR suggest endocrine diapause phenotypes. by Olga I. Kubrak (659970)

“…<b>C</b> The <i>dilp5</i> expression showed a profile similar to that of <i>dilp3</i>. <b>D</b> The <i>dilp6</i> expression was significantly higher throughout diapause than in C1 controls, but with a slight decrease after 6 weeks (D6). …”

Procedural characteristics. by Huimin Xian (20390006)

“…Quantitative flow ratio (QFR), as a newer non-invasive tool for identifying functional coronary stenosis and determining the presence of functional CR (FCR), may open up a new perspective for studying the above issues. …”

Values of <i>C</i>_ECF (10^-3 <i>μ</i> mol L^-1) at several locations within the brain unit for different values of <i>P</i> and <i>v</i><sub>blood</s... by Esmée Vendel (9411408)

“…<p>a) Locations within the 3D brain unit. Corner 1: (x,y,z) = (r,r,r), Corner 2: (x,y,z) = (x_r-r,y_r-r,z_r-r), Edge: (x,y,z) = (0, ,), Middle: (x,y,z) = (,,). b) Values of <i>C</i>_ECF are shown for a low ((<i>P</i> = 0.01⋅10^-8 m s^-1), default (<i>P</i> = 0.1⋅10^-8 m s^-1) and high (<i>P</i> = 1⋅10^-8 m s^-1) value of <i>P</i> in the top, middle and bottom table, respectively. …”

Table_2_Evaluation of Mannose Binding Lectin Gene Variants in Pediatric Influenza Virus-Related Critical Illness.DOCX by Emily R. Levy (6679511)

“…We confirmed a prior report of higher B allele carriage in a relatively small number of young individuals with influenza-MRSA associated death.…”